Conotoxin and biological preparation method and application thereof
A conotoxin and biological technology, applied in the field of biological preparation of conotoxin, can solve the problems of inability to process and remove the N-terminal signal peptide sequence, unable to solve the problem of C-terminal amidation, small conotoxin molecules, etc. , to achieve the effect of large-scale production, complete post-processing and low production cost
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0028] Example 1 Optimization of conotoxin αACT gene and its expression in silkworm
[0029] 1. Cloning and expression of conotoxin αACT gene
[0030] 1.1. Preparation of relevant solutions and media (Joseph et al., Molecular Cloning Experiment Guide, Third Edition, 2002; Osper et al., Refined Molecular Biology Guide, 1998)
[0031] Solution I: 50mmol / L glucose, 25mmol / L Tris-HCl (pH8.0), 10mmol / LEDTA.
[0032] Solution II: 0.2mol / L NaOH, 1% SDS (prepared and used immediately).
[0033] Solution III: 100mL system, 80mL 5mol / L potassium acetate, 12mL glacial acetic acid, 8mL ddH2O.
[0034] TAE (50×): 242g Tris base, 57.1mL glacial acetic acid, 100mL 0.5mol / LEDTA (pH8.0), dilute to 1000mL with sterile water.
[0035] TER solution: Pancreatic RNAse (RNAse A) was dissolved in 10mM Tris-HCl, 15mMNaCl, made into a 10mg / mL stock solution and stored at -20°C, then diluted with 1×TE buffer to a 20µg / mL working solution, kept at 4°C save.
[0036] PPt Buffer: 22 mL of isopropanol;...
experiment example 1
[0132] Experimental example 1 Evaluation of the analgesic activity of conotoxin αACT1
[0133] The modified conotoxin αACT1 product expressed in silkworm in Example 1 was evaluated for analgesic activity (preliminary experiments showed that the analgesic treatment was carried out with the conotoxin αACT gene expression product not optimized and transformed in Example 1, Its dosage should be 5-10 times higher than the transformed conotoxin αACT1 gene product to have the same analgesic effect; pain activity evaluation).
[0134] According to the pathological pain that peripheral nerve injury causes to be preserved to the greatest extent, the standard of simplicity of operation, reliability, repeatability, effectiveness and practicability, has selected classic formaldehyde acute pain model, evaluates conotoxin αACT1 (embodiment 1 Analgesic activity of conotoxin αACT1 product expressed in silkworm.
[0135] Firstly, formaldehyde (2.5%) acute inflammatory pain model was establish...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com